A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Virology

• Publication date

  2004-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VIROL.2003.12.008PMID 15033568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene—influence of the transgene expression on pathogenesis

  2005cited by this paper
• Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes

  2005cited by this paper
• Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.

  2002cited by this paper
• Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

  2002cited by this paper
• Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.

  2001influential reference
• Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.

  2000cited by this paper
• Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.

  2000cited by this paper
• Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse model

  1999cited by this paper
• Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.

  1998cited by this paper
• Retrograde transport of intact poliovirus through the axon via the fast transport system.

  1998cited by this paper
• New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.

  1997cited by this paper
• Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut

  1997cited by this paper
• Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.

  1997cited by this paper
• A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.

  1996cited by this paper
• Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence

  1996cited by this paper
• Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.

  1995cited by this paper
• A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA

  1995cited by this paper
• Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.

  1995cited by this paper
• Molecular characterization of the cellular receptor for poliovirus.

  1994cited by this paper
• Amino acid residues on human poliovirus receptor involved in interaction with poliovirus.

  1994cited by this paper
• Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence

  1994cited by this paper
• The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.

  1994cited by this paper
• Poliovirus spreads from muscle to the central nervous system by neural pathways.

  1992cited by this paper
• Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice

  1992cited by this paper
• Functional domains of the poliovirus receptor.

  1991cited by this paper
• Mutational analysis of the cellular receptor for poliovirus

  1991cited by this paper
• Transgenic mice susceptible to poliovirus.

  1991cited by this paper
• Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

  1990cited by this paper
• The poliovirus receptor protein is produced both as membrane‐bound and secreted forms.

  1990cited by this paper
• Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

  1989cited by this paper
• Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world.

  1985cited by this paper
• Histopathologic basis of clinical findings in poliomyelitis.

  1949cited by this paper
• Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues.

  1949cited by this paper
• Probit Analysis: A Statistical Treatment of the Sigmoid Response Curve.

  1948cited by this paper
• Distribution of lesions of the brain stem in poliomyelitis.

  1948cited by this paper
• AN EXPERIMENTAL STUDY OF THE ROLE OF NEURONES IN THE DISSEMINATION OF POLIOMYELITIS VIRUS IN THE NERVOUS SYSTEM

  1940cited by this paper

• Enterovirus and Parechovirus Neurologic Infections in Children: Clinical Presentations and Neuropathogenesis.

  2025cites this paper
• Bridging the gap between emerging models and humans by learning from polio animal studies: A systematic review

  2022cites this paper
• TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia

  2021cites this paper
• A defective viral genome strategy elicits broad protective immunity against respiratory viruses

  2021cites this paper
• Enterovirus and Encephalitis

  2020cites this paper
• TDP-43 stabilizes transcripts encoding stress granule protein G3BP1: potential relevance to ALS/FTD

  2020cites this paper
• Neuropathology in Neonatal Mice After Experimental Coxsackievirus B2 Infection Using a Prototype Strain, Ohio-1.

  2019cites this paper
• Recombination in Enteroviruses, a Multi-Step Modular Evolutionary Process

  2019cites this paper
• Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5’ Untranslated Region

  2015cites this paper
• Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.

  2012cites this paper
• Exposure, uptake, distribution and toxicity of nanomaterials in humans.

  2010cites this paper
• Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals.

  2009cites this paper
• Recombination between Polioviruses and Co-Circulating Coxsackie A Viruses: Role in the Emergence of Pathogenic Vaccine-Derived Polioviruses

  2009cites this paper
• The pathogenesis of poliomyelitis: what we don't know.

  2008cites this paper
• [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].

  2008cites this paper
• Exposure , Uptake , Distribution and Toxicity of Nanomaterials

  2008cites this paper
• Virology of the post-polio syndrome

  2007cites this paper
• Establishment of a Poliovirus Oral Infection System in Human Poliovirus Receptor-Expressing Transgenic Mice That Are Deficient in Alpha/Beta Interferon Receptor

  2007cites this paper
• One hundred years of poliovirus pathogenesis.

  2006cites this paper
• Children’s vaccines do not induce cross reactivity against SARS-CoV

  2006cites this paper
• Containment of Polioviruses After Eradication and OPV Cessation: Characterizing Risks to Improve Management

  2006cites this paper
• Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo

  2005cites this paper
• Poliovirus, pathogenesis of poliomyelitis, and apoptosis.

  2005cites this paper
• Stringent Requirement for the C Protein of Wild-Type Measles Virus for Growth both In Vitro and in Macaques

  2005cites this paper
• Poliovirus proves IRES-istible in vivo

  2004cites this paper
• Poliovirus proves IRES-istible in vivo.

  2004cites this paper